Zobrazeno 1 - 10
of 420
pro vyhledávání: '"β galactocerebrosidase"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2013 Dec . 110(51), 20479-20484.
Externí odkaz:
https://www.jstor.org/stable/23761579
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Berardi, Anna Sara, Pannuzzo, Giovanna, Graziano, Adriana, Costantino-Ceccarini, Elvira, Piomboni, Paola, Luddi, Alice
Publikováno v:
In Molecular Genetics and Metabolism August 2014 112(4):294-301
Autor:
Alba Nin-Hill, Carme Rovira
Publikováno v:
ACS Catalysis. 10:12091-12097
Krabbe disease is a neurodegenerative disorder related to misfunction of β-galactocerebrosidase (GALC), a glycosidase that cata-lyzes the cleavage of β-galactosidic bonds in glycosphingolipids. Her...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7167428c048ee26001dad70849f3dbdf
https://doi.org/10.1021/acscatal.0c02609
https://doi.org/10.1021/acscatal.0c02609
Publikováno v:
Chinese Journal of Biochemistry & Molecular Biology. Apr2024, Vol. 40 Issue 4, p493-503. 11p.
Publikováno v:
Viuff, A, Salamone, S, McLoughlin, J, Deane, J E & Jensen, H H 2021, ' The Bicyclic Form of galacto-Noeurostegine Is a Potent Inhibitor of β-Galactocerebrosidase ', ACS Medicinal Chemistry Letters, vol. 12, no. 1, pp. 56-59 . https://doi.org/10.1021/acsmedchemlett.0c00377
Competitive inhibitors of galactocerebrosidase (GALC) could be candidates for pharmacological chaperone therapy of patients with Krabbe disease. The known and selective nortropane-type iminosugar galacto-noeurostegine has been found to competitively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b516b8ceb03f29ca8c3cf5f85df9945
https://www.repository.cam.ac.uk/handle/1810/319002
https://www.repository.cam.ac.uk/handle/1810/319002
Autor:
Hisako Akiyama
Publikováno v:
Trends in Glycoscience and Glycotechnology. 33:J75-J75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf6be0de936de634b8efbf2cc1862cb
https://doi.org/10.4052/tigg.2104.6j
https://doi.org/10.4052/tigg.2104.6j
Autor:
Hisako Akiyama
Publikováno v:
Trends in Glycoscience and Glycotechnology. 31:J111-J112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecfd4a14613e0b6ef71221f9941fc7d
https://doi.org/10.4052/tigg.1965.6j
https://doi.org/10.4052/tigg.1965.6j
Autor:
Viuff A; Department of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark., Salamone S; Department of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark., McLoughlin J; Department of Clinical Neuroscience, Cambridge Institute of Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, U.K., Deane JE; Department of Clinical Neuroscience, Cambridge Institute of Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, U.K., Jensen HH; Department of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 Dec 18; Vol. 12 (1), pp. 56-59. Date of Electronic Publication: 2020 Dec 18 (Print Publication: 2021).